Skip to main content
. 2022 Jun 14;96(13):e00509-22. doi: 10.1128/jvi.00509-22

FIG 12.

FIG 12

Assessment of recognition and killing capabilities of SARS-CoV-2 membrane/ORF1ab-specific T cell clones. (A) Representative recognition and killing capabilities of SARS-COV-2-specific CD4+ and CD8+ T cell clones against peptide-pulsed, CFSELow target cells. (B) Percentage killing lysis at different effector/target ratios of CD4+ and CD8+ T cell clones. (C and D) Flow cytometry analysis of intracellular cytokines secretion of IFN-γ and GzmB by CD4+ and CD8+ T cell clones in the presence of peptide-pulsed target cells.